Another NYT Nudge Toward End-of-Life Health Care Rationing?

Andrew Pollack greets a new tumor-shrinking drug with concerns about costs, as if cancer-fighting drugs come cheap: "A newly approved chemotherapy drug will cost about $30,000 a month, a sign that ...

NYT, Heal Thyself

The Times worries that health insurance plans may not cover a new cancer therapy - but if the Times was in charge of health care, would there be any new kinds of therapies developed for insurance ...

The Times' War Against Health Care?

Tuesday's front page features the fourth front-page story arguing for limiting health care choices in the name of cost savings.

Slanting the Cervical Cancer Vaccine Story

"Groups wary of drug industry motives" versus "religious and cultural conservatives." What, no liberals?
Syndicate content